Role of nesfatin-1 in a rat model of visceral hypersensitivity

World Journal of Gastroenterology

Volumn 19, Issue 22, 2013, Pages 3487-3493

  Jia, Fang Yuan ^a   Li, Xue Liang ^a   Li, Tian Nv ^a   Wu, Jing ^a   Xie, Bi Yun ^a   Lin, Lin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Corticotropin releasing factor; Intracerebroventricular injection; Irritable bowel syndrome; Nesfatin 1; Visceral hypersensitivity

Indexed keywords

ANOREXIGENIC AGENT; CORTICOTROPIN RELEASING FACTOR; MYELOPEROXIDASE; NESFATIN 1; UNCLASSIFIED DRUG;

ABDOMINAL REFLEX; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON DILATATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROMYOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HYPERALGESIA; HYPERSENSITIVITY; MALE; NEWBORN; NONHUMAN; RAT; VISCERAL HYPERSENSITIVITY; WITHDRAWAL REFLEX;

EID: 84879047536     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i22.3487     Document Type: Article

References (27)

1. Kanazawa M, Hongo M, Fukudo S. Visceral hypersensitivity in irritable bowel syndrome. J Gastroenterol Hepatol 2011; 26 Suppl 3: 119-121 [DOI: 10.1111/j.1440-1746.2011.06640.x]
2. Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, Tsuchiya T, Monden T, Horiguchi K, Yamada M, Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006; 443: 709-712
3. Stengel A, Goebel M, Wang L, Rivier J, Kobelt P, Mönnikes H, Lambrecht NW, Taché Y. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology 2009; 150: 4911-4919 [DOI: 10.1210/en.2009-0578]
4. Goebel M, Stengel A, Wang L, Taché Y. Restraint stress activates nesfatin-1-immunoreactive brain nuclei in rats. Brain Res 2009; 1300: 114-124 [DOI: 10.1016/j.brainres.2009.08.082]
5. Brailoiu GC, Dun SL, Brailoiu E, Inan S, Yang J, Chang JK, Dun NJ. Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 2007; 148: 5088-5094
6. Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 2004; 44: 525-557
7. Stengel A, Taché Y. Neuroendocrine control of the gut during stress: corticotropin-releasing factor signaling pathways in the spotlight. Annu Rev Physiol 2009; 71: 219-239 [DOI: 10.1146/annurev.physiol.010908.163221]
8. Lariviere WR, Melzack R. The role of corticotropin-releasing factor in pain and analgesia. Pain 2000; 84: 1-12
9. Mousa SA, Bopaiah CP, Richter JF, Yamdeu RS, Schäfer M. Inhibition of inflammatory pain by CRF at peripheral, spinal and supraspinal sites: involvement of areas coexpressing CRF receptors and opioid peptides. Neuropsychopharmacology 2007; 32: 2530-2542
10. Qian AH, Liu XQ, Yao WY, Wang HY, Sun J, Zhou L, Yuan YZ. Voltage-gated potassium channels in IB4-positive colonic sensory neurons mediate visceral hypersensitivity in the rat. Am J Gastroenterol 2009; 104: 2014-2027 [DOI: 10.1038/ajg.2009.227]
11. Al-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 2000; 119: 1276-1285
12. Traub RJ, Tang B, Ji Y, Pandya S, Yfantis H, Sun Y. A rat model of chronic postinflammatory visceral pain induced by deoxycholic acid. Gastroenterology 2008; 135: 2075-2083 [DOI: 10.1053/j.gastro.2008.08.051]
13. Martínez V, Taché Y. Role of CRF receptor 1 in central CRFinduced stimulation of colonic propulsion in rats. Brain Res 2001; 893: 29-35
14. Bonaz B, Taché Y. Water-avoidance stress-induced c-fos expression in the rat brain and stimulation of fecal output: role of corticotropin-releasing factor. Brain Res 1994; 641: 21-28
15. Mayer EA, Naliboff BD, Chang L, Coutinho SV. V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2001; 280: G519-G524
16. Lin C, Al-Chaer ED. Long-term sensitization of primary afferents in adult rats exposed to neonatal colon pain. Brain Res 2003; 971: 73-82
17. Bouin M, Plourde V, Boivin M, Riberdy M, Lupien F, Laganière M, Verrier P, Poitras P. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002; 122: 1771-1777
18. Shimizu H, Oh-I S, Hashimoto K, Nakata M, Yamamoto S, Yoshida N, Eguchi H, Kato I, Inoue K, Satoh T, Okada S, Yamada M, Yada T, Mori M. Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 2009; 150: 662-671 [DOI: 10.1210/en.2008-0598]
19. Stengel A, Goebel M, Yakubov I, Wang L, Witcher D, Coskun T, Taché Y, Sachs G, Lambrecht NW. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 2009; 150: 232-238 [DOI: 10.1210/en.2008-0747]
20. Gonzalez R, Tiwari A, Unniappan S. Pancreatic beta cells colocalize insulin and pronesfatin immunoreactivity in rodents. Biochem Biophys Res Commun 2009; 381: 643-648 [DOI: 10.1016/j.bbrc.2009.02.104]
21. Li QC, Wang HY, Chen X, Guan HZ, Jiang ZY. Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept 2010; 159: 72-77 [DOI: 10.1016/j.regpep.2009.11.003]
22. Pan W, Hsuchou H, Kastin AJ. Nesfatin-1 crosses the bloodbrain barrier without saturation. Peptides 2007; 28: 2223-2228
23. Price TO, Samson WK, Niehoff ML, Banks WA. Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1. Peptides 2007; 28: 2372-2381
24. Martinez V, Taché Y. CRF1 receptors as a therapeutic target for irritable bowel syndrome. Curr Pharm Des 2006; 12: 4071-4088
25. Taché Y, Martinez V, Wang L, Million M. CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome. Br J Pharmacol 2004; 141: 1321-1330
26. Sagami Y, Shimada Y, Tayama J, Nomura T, Satake M, Endo Y, Shoji T, Karahashi K, Hongo M, Fukudo S. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut 2004; 53: 958-964
27. Yoshida N, Maejima Y, Sedbazar U, Ando A, Kurita H, Damdindorj B, Takano E, Gantulga D, Iwasaki Y, Kurashina T, Onaka T, Dezaki K, Nakata M, Mori M, Yada T. Stressorresponsive central nesfatin-1 activates corticotropin-releasing hormone, noradrenaline and serotonin neurons and evokes hypothalamic-pituitary-adrenal axis. Aging (Albany NY) 2010; 2: 775-784